title: Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia.
abstract: OBJECTIVE
  To propose a protocol for minimizing medical complications associated with the use of cyproterone, medroxyprogesterone, and depot leuprolide to treat paraphilia.
  
  
  METHODS
  Review of the relevant literature.
  
  
  RESULTS
  Certain patient populations should not be treated with these medications, and medical complications associated with each can be detected early and avoided.
  
  
  CONCLUSIONS
  For each drug, a series of screening tests prior to use and scheduled testing during use can minimize potential medical complications.
authors.affiliation: University of Ottawa, Ontario.
authors.forename: D R
authors.initials: DR
authors.lastname: Reilly
authors.forename: N J
authors.initials: NJ
authors.lastname: Delva
authors.forename: R W
authors.initials: RW
authors.lastname: Hudson
mesh_terms: D000284:Administration, Oral; D000726:Androgen Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D017373:Cyproterone Acetate / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007273:Injections, Intramuscular; D016729:Leuprolide / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008525:Medroxyprogesterone / Q000008:administration & dosage* / Q000009:adverse effects; D010262:Paraphilic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology
chemical_list: D000726:Androgen Antagonists; D017373:Cyproterone Acetate; D016729:Leuprolide; D008525:Medroxyprogesterone